Below are the most recent publications written about "Cardiologists" by people in Profiles.
-
Saksena S, Slee A, Merino JL, Goette A, Boriani G, Kowey PR, Piccini JP, Reiffel JA, Blomstr?m-Lundqvist C, Camm AJ. An international physician survey of current ablation practices in atrial fibrillation: An AIM-AF substudy. Heart Rhythm. 2025 09; 22(9):2174-2182.
-
Chowdhury D, Bansal N, Ansong A, Baker Smith C, Bauser-Heaton H, Choueiter N, Co-Vu J, Elliott P, Fuller S, Jain SS, Jone PN, Johnson JN, Karamlou T, Kipps AK, Laraja K, Lopez KN, Rasheed M, Ronai C, Sachdeva R, Saidi A, Snyder C, Sutton N, Stiver C, Taggart NW, Shaffer K, Williams R. Mind the Gap! Working Toward Gender Equity in Pediatric and Congenital Heart Disease: Present and Future. J Am Heart Assoc. 2024 05 07; 13(9):e032837.
-
Spears J, Liskov S, Camm AJ, Kowey PR. How Antiarrhythmic Drugs Are Being Used in Patients With Heart Failure: Results of a Global Survey of Cardiologists. Am J Cardiol. 2023 11 01; 206:60-62.
-
Rjoob K, McGilligan V, McAllister R, Bond R, Doolub G, Leslie SJ, Manktelow M, Knoery C, Shand J, Iftikhar A, McShane A, Mamas MA, Peace A. What do we mean by complex percutaneous coronary intervention? An assessment of agreement amongst interventional cardiologists for defining complexity. Catheter Cardiovasc Interv. 2023 07; 102(1):1-10.
-
Calogiuri G, Savage MP, Congedo M, Nettis E, Mirizzi AM, Foti C, Vacca A, Kounis NG. Is Adrenaline Always the First Choice Therapy of Anaphylaxis? An Allergist-cardiologist Interdisciplinary Point of View. Curr Pharm Des. 2023; 29(32):2545-2551.
-
Block RC, Bang M, Peterson A, Wong ND, Karalis DG. Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) - Results of a US national survey. J Clin Lipidol. 2021 Sep-Oct; 15(5):682-689.
-
Costa F, Mamas MA. Distal radial artery access for percutaneous coronary intervention: Convincing the sceptical cardiologist. Int J Cardiol. 2021 09 15; 339:33-34.
-
Wong ND, Bang M, Block RC, Peterson ALH, Karalis DG. Perceptions and Barriers on the Use of Proprotein Subtilisin/Kexin Type 9 Inhibitors in Heterozygous Familial Hypercholesterolemia (From a Survey of Primary Care Physicians and Cardiologists). Am J Cardiol. 2021 08 01; 152:57-62.
-
Aggarwal NR, Alasnag M, Mamas MA. Social media in the era of COVID-19. Open Heart. 2020 09; 7(2).
-
Topper SR, Levin DC, Hansberry DR, Guez D, Winokur RS, Adamo RD, Eschelman DJ. Trends in Percutaneous Embolization Procedures by Radiologists and Other Specialists. J Vasc Interv Radiol. 2020 06; 31(6):961-966.